In addition, with the application of a customized multiplex mutation assay, we found mutations involving EZH2 and CD79B in cases of FL and DLBCL in a similar rate to that reported for surgical pathology specimens. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.